0
ARTICLE |

Cost-effectiveness of Mammography Screening-Reply FREE

C. John Rosenquist, MD; Karen K. Lindfors, MD
JAMA. 1996;275(2):112-112. doi:10.1001/jama.1996.03530260025023
Text Size: A A A
Published online

In Reply.  —We appreciate the opportunity to respond to the provocative comments resulting from publication of our article.Drs Donnelly and Lo are concerned because elements of disutility (anxiety, fear, and the like) were not included in the model. These disutilities are often not analyzed because of the difficulty in assigning values. Positive utilities were also ignored, including knowledge that cancer is not present and establishment of better health habits.Drs Black and Tosteson suggest that we should analyze marginal cost-effectiveness of adding screening of the 40- to 49-year-old age group; this was the subject of a previous article.1 They are correct that the cost-effectiveness of screening in the 40- to 49-year-old age group is highly sensitive to the assumed reduction in mortality. This is illustrated in Table 7 of our article and in the previous study.1We have the following responses to the five concerns about our

REFERENCES

Rosenquist CJ, Lindfors KK.  Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology . 1994;;191:647-650.
Shapiro S, Venet W, Strax P, Venet L, Roeser R.  Ten to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst . 1982;;69:349-355.
Lindfors KK, Rosenquist CJ.  Needle core biopsy guided with mammography: a study of cost effectiveness. Radiology . 1994;;190:217-222.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Rosenquist CJ, Lindfors KK.  Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology . 1994;;191:647-650.
Shapiro S, Venet W, Strax P, Venet L, Roeser R.  Ten to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst . 1982;;69:349-355.
Lindfors KK, Rosenquist CJ.  Needle core biopsy guided with mammography: a study of cost effectiveness. Radiology . 1994;;190:217-222.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.